
Prime Medicine, Inc.
Prime Medicine, Inc. (PRME)
WebsitePrice
Market cap
Next catalystPhase 1/2 initiation planned; prior 2026 guidance not withdrawnPM647 — planned global Phase 1/2 AATD trial · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved